concept

MITOCHONDRIAL DYSFUNCTION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about MITOCHONDRIAL DYSFUNCTION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

3392Connections

7Hypotheses

30Analyses

50Outgoing

50Incoming

0Experiments

20Debates

Summary

MITOCHONDRIAL DYSFUNCTION is a concept in neurodegeneration research. Key relationships include: activates, therapeutic target, associated with. Associated with ALS, ALZHEIMER, ALZHEIMER'S. Connected to 1902 entities in the SciDEX knowledge graph.

View on Wiki →

AI portrait of MITOCHONDRIAL DYSFUNCTION

AI-generated illustration · click image to enlarge

Regenerate portrait ↻

💡 Concept Info

Name	MITOCHONDRIAL DYSFUNCTION
Key Genes/Proteins	ABCA7, ABCG2, ACC, ACE, ACETYL-COA, ACHE
Related Diseases	ACETYLCHOLINE, Aging

Pathway Diagram

graph TD
    MITOCHONDRIAL_DYSFUNCTION["MITOCHONDRIAL DYSFUNCTION"]
    MITOCHONDRIAL_DYSFUNCTION -->|"causes"| neurodegeneration["neurodegeneration"]
    MITOCHONDRIAL_DYSFUNCTION -->|"causes"| Alzheimer_s_disease["Alzheimer's disease"]
    MITOCHONDRIAL_DYSFUNCTION -->|"activates"| oxidative_stress["oxidative stress"]
    MITOCHONDRIAL_DYSFUNCTION -->|"causes"| Parkinson_s_disease["Parkinson's disease"]
    MITOCHONDRIAL_DYSFUNCTION -->|"causes"| age_related_macular_degenerati["age-related macular degeneration"]
    MITOCHONDRIAL_DYSFUNCTION -->|"activates"| reactive_oxygen_species["reactive oxygen species"]
    PS_NPs["PS-NPs"] -->|"causes"| MITOCHONDRIAL_DYSFUNCTION
    melatonin["melatonin"] -.protects against.-> MITOCHONDRIAL_DYSFUNCTION
    defective_mitophagy["defective mitophagy"] -->|"causes"| MITOCHONDRIAL_DYSFUNCTION
    GBA["GBA"] -->|"causes"| MITOCHONDRIAL_DYSFUNCTION
    SNCA["SNCA"] -->|"causes"| MITOCHONDRIAL_DYSFUNCTION
    AGEs["AGEs"] -->|"causes"| MITOCHONDRIAL_DYSFUNCTION
    Autophagy["Autophagy"] -.protects against.-> MITOCHONDRIAL_DYSFUNCTION
    MTOR["MTOR"] -->|"regulates"| MITOCHONDRIAL_DYSFUNCTION

Outgoing (1934)

Target	Relation	Type	Str
Inflammation	causes	disease	1.00
ATP	activates	gene	1.00
MITOCHONDRIA	causes	gene	1.00
Oxidative Stress	therapeutic_target	pathway	1.00
Mitochondrial Function	activates	pathway	1.00
Oxidative Stress	causes	pathway	1.00
Mitophagy	regulates	pathway	1.00
Mitochondrial Function	therapeutic_target	pathway	1.00
Parkinson	therapeutic_target	disease	1.00
Neurodegeneration	activates	disease	1.00
Als	regulates	disease	1.00
Als	associated_with	disease	1.00
Fibrosis	activates	disease	1.00
Als	therapeutic_target	disease	1.00
Mtor	activates	pathway	1.00
MITOCHONDRIA	associated_with	gene	1.00
Cancer	therapeutic_target	disease	1.00
Parkinson	associated_with	disease	1.00
Oxidative Stress	regulates	pathway	1.00
AGING	activates	gene	1.00
Apoptosis	activates	pathway	1.00
Parkinson	activates	disease	1.00
Cancer	associated_with	disease	1.00
Oxidative Stress	activates	pathway	1.00
Alzheimer	activates	disease	1.00
Senescence	associated_with	disease	1.00
Aging	associated_with	disease	1.00
Parkinson	causes	disease	1.00
NEUROINFLAMMATION	activates	gene	1.00
MTDNA	activates	gene	1.00
MITOCHONDRIA	activates	gene	1.00
Apoptosis	therapeutic_target	pathway	1.00
Inflammation	activates	disease	1.00
Als	causes	disease	1.00
Inflammation	associated_with	disease	1.00
Cardiac	therapeutic_target	disease	1.00
Cardiac	activates	disease	1.00
AGING	associated_with	gene	1.00
Als	activates	disease	1.00
Neurodegeneration	causes	disease	1.00
Inflammasome	activates	pathway	1.00
Mitophagy	activates	pathway	1.00
Oxidative Phosphorylation	activates	pathway	1.00
MITOCHONDRIA	therapeutic_target	gene	1.00
Autophagy	activates	pathway	1.00
Neuroinflammation	activates	disease	1.00
Cardiovascular	associated_with	disease	1.00
Oxidative Stress	treats	pathway	1.00
Aging	activates	disease	1.00
Neuroinflammation	therapeutic_target	disease	1.00

Incoming (1458)

Source	Relation	Type	Str
ROS	activates	gene	1.00
PARKINSON'S DISEASE	associated_with	gene	1.00
OXIDATIVE STRESS	inhibits	gene	1.00
PARKINSON	therapeutic_target	gene	1.00
CANCER	activates	gene	1.00
ALZHEIMER	associated_with	gene	1.00
ROS	associated_with	gene	1.00
ALZHEIMER	therapeutic_target	gene	1.00
MITOPHAGY	regulates	gene	1.00
OXIDATIVE STRESS	therapeutic_target	gene	1.00
ALZHEIMER'S DISEASE	associated_with	gene	1.00
OXIDATIVE STRESS	regulates	gene	1.00
OXIDATIVE STRESS	treats	gene	1.00
PARKINSON'S DISEASE	therapeutic_target	gene	1.00
PARKINSON'S DISEASE	activates	gene	1.00
NEURODEGENERATION	activates	gene	1.00
AGING	associated_with	gene	1.00
PARKINSON	associated_with	gene	1.00
OXIDATIVE STRESS	activates	gene	1.00
APOPTOSIS	activates	gene	1.00
CYTOKINES	activates	gene	1.00
INFLAMMATION	activates	gene	1.00
MITOPHAGY	activates	gene	1.00
NEURODEGENERATIVE DISEASES	therapeutic_target	gene	1.00
INFLAMMATION	therapeutic_target	gene	1.00
AUTOPHAGY	activates	gene	1.00
OXIDATIVE STRESS	causes	gene	1.00
NEURODEGENERATION	therapeutic_target	gene	1.00
NEURODEGENERATION	associated_with	gene	1.00
NEURODEGENERATION	causes	gene	1.00
SIRT1	activates	gene	1.00
APOPTOSIS	targets	gene	1.00
ALZHEIMER'S DISEASE	therapeutic_target	gene	1.00
ALZHEIMER	activates	gene	1.00
INFLAMMATION	associated_with	gene	1.00
OXIDATIVE STRESS	associated_with	gene	1.00
AKT	activates	gene	1.00
PINK1	activates	gene	1.00
PARKINSON	activates	gene	1.00
GENES	activates	gene	1.00
NF-ΚB	activates	gene	1.00
CANCER	associated_with	gene	1.00
AUTOPHAGY	associated_with	gene	1.00
MITOCHONDRIAL DNA	associated_with	gene	1.00
INFLAMMATION	inhibits	gene	1.00
AMYLOID	therapeutic_target	gene	1.00
TAU	activates	gene	1.00
NEURODEGENERATIVE DISEASES	associated_with	gene	1.00
ALZHEIMER'S DISEASE	activates	gene	1.00
ROS	therapeutic_target	gene	1.00

Targeting Hypotheses (7)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
TREM2-Mediated Mitochondrial Dysfunction in Neurodegeneratio	0.642	neurodegeneration	Gene expression changes in aging mouse b
Mitochondrial Dysfunction Increasing Neuronal Vulnerability	0.470	neurodegeneration	How does APOE4 mechanistically increase
Mitochondrial Dysfunction in Neurodegeneration	0.460	-	-
C1q Inhibition Prevents Synaptic Mitochondrial Dysfunction v	0.455	neurodegeneration	Why does PRKN-mediated mitophagy, typica
Mitochondrial Dysfunction-Mediated Neurodegeneration in Alzh	0.380	-	Survival Analysis of AD Patient Cohorts:

Hippocampal mitochondrial dysfunction accelerates with age a	0.374	Alzheimer's disease	Allen Mouse Brain Aging Atlas: cross-age
Combination Gene Therapy Targeting RGS6 and Parkin or PINK1	0.317	neurodegeneration	Does RGS6 upregulation or D2 autorecepto

Mentioning Analyses (30)

Scientific analyses that reference this entity

Oxidative Stress Upstream of TDP-43 Mislocalization in ALS Motor Neurons

neurodegeneration | 2026-04-27 | 0 hypotheses

What are the mechanisms by which microglial senescence contributes to ALS pathol

neurodegeneration | 2026-04-26 | 12 hypotheses Top: 0.878

Allen Mouse Brain Aging Atlas: cross-age gene expression analysis

neurodegeneration | 2026-04-23 | 8 hypotheses Top: 0.519

Comparative epigenetic signatures: DNA methylation age acceleration and histone

neurodegeneration | 2026-04-18 | 0 hypotheses

scRNA-seq Processing and Cell Type Annotation of AD Brain

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.618

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (4)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year
Genomic ncRNAs regulating mitochondrial function in neurodegeneration: a neglect [PMID:40581642]	Sanadgol N, Samadi M, Voelz C, Khalseh R	Cell & bioscience	2025
The Relationships Among Metal Homeostasis, Mitochondria, and Locus Coeruleus in [PMID:35635600]	["Nakagawa Yutaka", "Yamada Shizuo"]	Cellular and molecular neurobi	2023
Crosstalk Between Dysfunctional Mitochondria and Inflammation in Glaucomatous Ne [PMID:34366851]	Jassim AH, Inman DM, Mitchell CH	Frontiers in pharmacology	2021
How the Wnt signaling pathway protects from neurodegeneration: the mitochondrial [PMID:25999816]	["Arr\u00e1zola Macarena S", "Silva-Alva	Frontiers in cellular neurosci	2015

Debates (20)

Multi-agent debates referencing this entity

Can targeting oxidative stress pathways (NRF2, SOD1, mitochondrial ROS) upstream

active · Rounds: 6 · Score: 0.62 · 2026-04-27

Extended debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Debate: TBK1 Loss Locks Microglia in an Aged/Senescent Transcriptional State, Fu

closed · Rounds: 4 · Score: 0.33 · 2026-04-27

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.44 · 2026-04-27

Investigate how microglial senescence drives ALS progression through inflammatio

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: SASP Modulation Rather Than Cell Elimination

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

What are the mechanisms by which microglial senescence contributes to ALS pathol

closed · Rounds: 6 · Score: 0.75 · 2026-04-26

How does gene expression change across age groups (young/middle/old) in hippocam

closed · Rounds: 4 · Score: 1.00 · 2026-04-24

Related Research

Hypotheses and analyses mentioning MITOCHONDRIAL DYSFUNCTION in their description or question text

Hippocampal mitochondrial dysfunction accelerates with age and drives regional A

Score: 0.374 · Alzheimer's disease · 2026-04-23

## Mechanistic Overview Hippocampal mitochondrial dysfunction accelerates with age and drives regional AD vulnerability

Combination Gene Therapy Targeting RGS6 and Parkin or PINK1 to Address Mitochond

Score: 0.317 · neurodegeneration · 2026-04-18

## Mechanistic Overview Combination Gene Therapy Targeting RGS6 and Parkin or PINK1 to Address Mitochondrial Dysfunction

MITOCHONDRIAL DYSFUNCTION

Understanding Entity Pages

Summary

Pathway Diagram

Outgoing (1934)

Incoming (1458)

Targeting Hypotheses (7)

Mentioning Analyses (30)

Oxidative Stress Upstream of TDP-43 Mislocalization in ALS Motor Neurons

What are the mechanisms by which microglial senescence contributes to ALS pathol

Allen Mouse Brain Aging Atlas: cross-age gene expression analysis

Comparative epigenetic signatures: DNA methylation age acceleration and histone

scRNA-seq Processing and Cell Type Annotation of AD Brain

Gene Regulatory Network Inference in Alzheimer's Disease

Proteomics Differential Expression in AD CSF and Brain Tissue

Metabolomic signatures of neurodegeneration: metabolic reprogramming in aging br

What upstream mechanisms trigger p53 activation specifically in response to poly

What molecular mechanisms cause iPLA2β deficiency to specifically damage mitocho

How do ALS-associated OPTN mutations mechanistically disrupt Rab8a binding and c

What molecular mechanism causes VCP mutations to trigger aberrant HIF-1α activat

Do transferred mitochondria from diseased astrocytes carry pathological damage t

Does tau aggregation specifically cause PS externalization in vesicles independe

Does tau aggregation specifically cause PS externalization in living cells versu

What mechanisms underlie TDP-43's contribution to cognitive impairment severity

How do different organelle-specific autophagy pathways coordinate during neurode

What is the optimal therapeutic window timing for autophagy enhancement versus s

How does APOE4 mechanistically increase TDP-43 pathology frequency in Alzheimer'

What determines the specificity of TDP-43-induced mitochondrial DNA release for

Do APOE4-driven senescent astrocytes cause neurodegeneration or represent a prot

What is the optimal therapeutic window for microglial reprogramming before irrev

Quantitative proteomics of the aging synapse in early Alzheimer disease

Senescent cell clearance as neurodegeneration therapy

Does TFEB dysfunction cause neurodegeneration or represent a compensatory respon

Gene expression changes in aging mouse brain predicting neurodegenerative vulner

CRISPR-based therapeutic approaches for neurodegenerative diseases

Cell type vulnerability debate in Alzheimer's disease (SEA-AD v4)

GBA-Synuclein Loop Therapeutics for PD

Autophagy-lysosome pathway convergence across neurodegenerative diseases

Experiments (0)

Related Papers (4)

Debates (20)

Can targeting oxidative stress pathways (NRF2, SOD1, mitochondrial ROS) upstream

Extended debate: Metabolic Reprogramming to Reverse Senescence

Debate: TBK1 Loss Locks Microglia in an Aged/Senescent Transcriptional State, Fu

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

Investigate how microglial senescence drives ALS progression through inflammatio

Hypothesis debate: SASP Modulation Rather Than Cell Elimination

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

What are the mechanisms by which microglial senescence contributes to ALS pathol

How does gene expression change across age groups (young/middle/old) in hippocam

Related Research

Hippocampal mitochondrial dysfunction accelerates with age and drives regional A

Combination Gene Therapy Targeting RGS6 and Parkin or PINK1 to Address Mitochond